News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Videos|December 17, 2021

Introduction: From Evidence to Implementation: Clarifications Around USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

Author(s)Ryan Haumschild, PharmD, MS, MBA

Episodes in this series

EP. 1 Introduction: From Evidence to Implementation: Clarifications Around USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

EP. 1 Introduction: From Evidence to Implementation: Clarifications Around USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

EP. 2 Uptake of HIV PrEP Therapy

EP. 2 Uptake of HIV PrEP Therapy

EP. 3 Unmet Needs for HIV PrEP Therapy

EP. 3 Unmet Needs for HIV PrEP Therapy

EP. 4 Barriers to Access for HIV PrEP

EP. 4 Barriers to Access for HIV PrEP

EP. 5 Overcoming Barriers to Access HIV PrEP

EP. 5 Overcoming Barriers to Access HIV PrEP

EP. 6 Role of USPSTF Guidelines for Access to HIV PrEP

EP. 6 Role of USPSTF Guidelines for Access to HIV PrEP

EP. 7 Implications of USPSTF Grade A Rating of HIV PrEP

EP. 7 Implications of USPSTF Grade A Rating of HIV PrEP

EP. 8 Understanding Implementation of USPSTF Guidelines for HIV PrEP

EP. 8 Understanding Implementation of USPSTF Guidelines for HIV PrEP

EP. 9 USPSTF Guidelines for HIV PrEP: Coverage for Drugs vs Ancillary Services

EP. 9 USPSTF Guidelines for HIV PrEP: Coverage for Drugs vs Ancillary Services

EP. 10 USPSTF Guidelines for HIV PrEP: Using Medical Management Techniques

EP. 10 USPSTF Guidelines for HIV PrEP: Using Medical Management Techniques

EP. 11 USPSTF Guidelines: Approaching Optimal Therapy for HIV PrEP

EP. 11 USPSTF Guidelines: Approaching Optimal Therapy for HIV PrEP

EP. 12 Unmet Needs for USPSTF Guidelines for HIV PrEP

EP. 12 Unmet Needs for USPSTF Guidelines for HIV PrEP

EP. 13 Using Real-World Evidence for HIV PrEP Policies

EP. 13 Using Real-World Evidence for HIV PrEP Policies

EP. 14 COVID-19’s Effect on Access to HIV PrEP Therapy

EP. 14 COVID-19’s Effect on Access to HIV PrEP Therapy

EP. 15 Improving Access and Uptake of HIV PrEP

EP. 15 Improving Access and Uptake of HIV PrEP

EP. 16 Overcoming HIV PrEP Access Barriers With Advocacy Groups

EP. 16 Overcoming HIV PrEP Access Barriers With Advocacy Groups

EP. 17 Key Takeaways for the Management of HIV PrEP

EP. 17 Key Takeaways for the Management of HIV PrEP

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Understanding Real-World MRI Utilization for ED Dizziness: Ava L. Liberman, MD

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text